The aim of this study was to investigate the clinical characteristics of acute hepatitis A during a recent outbreak in Korea. Data of patients diagnosed with acute hepatitis A from 2007 to 2009 were collected from 21 tertiary hospitals retrospectively. Their demographic, clinical, and serological characteristics and their clinical outcomes were analyzed. A total of 4,218 patients (mean age 33.3 yr) were included. The median duration of admission was 9 days. The mean of the highest ALT level was 2,963 IU/L, total bilirubin was 7.3 mg/dL, prothrombin time INR was 1.3. HBsAg was positive in 3.7%, and anti-HCV positive in 0.7%. Renal insufficiency occurred in 2.7%, hepatic failure in 0.9%, relapsing hepatitis in 0.7%, and cholestatic hepatitis in 1.9% of the patients. Nineteen patients (0.45%) died or were transplanted. Complications of renal failure or prolonged cholestasis were more frequent in patients older than 30 yr. In conclusion, most patients with acute hepatitis A recover uneventfully, however, complication rates are higher in patients older than 30 yr than younger patients. Preventive strategies including universal vaccination in infants and active immunization of hepatitis A to adult population should be considered for prevention of community-wide outbreaks of hepatitis A in Korea. http://dx.doi.org/10. 3346/jkms.2014.29.2.248 • J Korean Med Sci 2014 29: 248-253 
INTRODUCTION
The seroprevalence of hepatitis A differs by region according to urbanization and envi ronmental hygiene. Hepatitis A was endemic in Korea, and most people were infected asymptomatically in early childhood with lifelong immunity (1, 2) . However, the sero prevalence of hepatitis A has been decreasing over the last thirty years with the impro vement in the socioeconomic status and general public health (35). The decrease in hepatitis A virus (HAV) infection in young adults has resulted in the reduction of indi viduals who have been naturally immunized and has thus resulted in an increase in the adult population atrisk for acquiring the disease. Sporadic cases and regional out breaks of hepatitis A have been reported during the last 15 yr (610). The majority of patients develop selflimiting acute illness following HAV infection; however, the dis ease in adults can lead to serious complications. Recent studies showed increasing tendency in mean age and severity of the disease in symptomatic hepatitis A (11, 12) . Complications of hepatitis A, such as cholestatic hepatitis, relapsing hepatitis or pro longed course, and acute renal failure are not uncommon during the course of hepati tis A (1315). Symptomatic hepatitis A is increasing recently in Korea. The surveillance data from Korea Centers for Disease Control (KCDC) demonstrated that the number of hepatitis A patients was rapidly increasing, as an large number of patients developed hepatitis from 2007 to 2009 (16) .
The aims of this study were to investigate the clinical characteristics and complica tions of acute hepatitis A during the recent outbreak in Korea.
MATERIALS AND METHODS

Patients
Consecutive patients with acute hepatitis A, who visited hospi tals during the period between June 2007 and May 2009, were included in this study. From medical records of the institutions, the patients with hepatitis Arelated disease categorization codes were collected. A disease categorization codes include the In ternational Classification of Diseases 10 classification system, B15 (acute hepatitis A), B15.0 (hepatitis A with hepatic coma), and B15.9 (hepatitis A without hepatic coma). There were 21 tertiary hospitals from which the data was obtained and these hospitals are distributed throughout Korea. The patients' medi cal records were reviewed retrospectively. Acute hepatitis A was diagnosed by typical symptoms of acute hepatitis, by the pres ence of serum IgM antiHAV, and by the exclusion of other eti ologies of acute hepatitis including acute hepatitis B virus infec tion, drug, ischemia, autoimmune hepatitis, or vascular disorders.
Study design
Demographic, clinical, and laboratory data of liver function and viral markers were collected during the initial visit and at all fol low ups. In addition, we studied the incidences of complica tions such as acute renal failure, cholestatic hepatitis, relapsing hepatitis, fulminant hepatitis, death, or transplantation. Acute renal failure was defined as an increase in serum creatinine of 0.5 mg/dL over the baseline value or an increase of more than 50% over the baseline value in patients with no history of renal dysfunction (17) . Fulminant hepatic failure was defined as the presence of coagulopathy (prolongation of prothrombin time, international normalized ratio [INR] ≥ 1.5) and clinical evidence of hepatic encephalopathy within 26 weeks of symptom onset in the absence of preexisting liver disease (18) . Cholestatic he patitis was defined as persistence of cholestatic features (biliru bin > 2.5 mg/dL) for more than 8 weeks (19) . Relapsing hepati tis was defined as recurrence of symptoms and liver function abnormalities (ALT > × 2 nadir) after an apparent recovery (14) .
Statistical analysis
Continuous variables were expressed as mean and standard deviations, and the Student's ttest was employed to compare parametric data. Nonparametric data were analyzed with Mann Whitney Utest. Categorical variables were expressed as frequen cy distributions, and Chisquare or Fisher's exact tests were per formed. All P values were twotailed, and P values < 0.05 were considered statistically significant.
Ethics statement
This study's protocol was approved by the institutional review board of Konkuk University Hospital (IRB No. KUH 1010092) and each institute. Informed consent was waived by the board. The study was conducted in accordance with the principles of the Declaration of Helsinki.
RESULTS
Demographic data of hepatitis A patients
A total of 4,218 patients with acute hepatitis A were included. Male gender was predominant (62.4%). Mean age of the pa tients was 33.3 yr (standard deviation [SD] 7.7 yr, range 4 to 76 yr). Hepatitis A frequently occurred in their thirties (52.8%), and 17.6% of the patients was over forty years old (Fig. 1) . Among the 4,218 patients, 3,555 (59.1%) were admitted via emergency room for severe symptoms. The median duration of admission was 9 days (SD 5.1 days, range 2 to 59 days). During one year, the occurrence of hepatitis A peaked during the months April to August (Fig. 2) .
Clinical manifestations
The frequent symptoms of hepatitis A are summarized in Table 1. Gastrointestinal symptoms and fever were most frequent, and jaundice was observed in approximately 50% of the patients. Laboratory findings showed severe hepatic dysfunction (Table  2 ). Mean peak ALT was 2,963 IU/L (SD 2,412) with a mean peak bilirubin of 7.3 mg/dL (SD 5.3). Serologic data showed HBsAg was positive in 3.7% (153/4,049), antiHBs in 63.7% (2,628/3,936), and antiHCV was positive in 0.7% (29/3,937), respectively.
Outcomes of hepatitis A
Fulminant hepatic failure developed in 0.91% of hepatitis A pa tients. Table 3 demonstrates mortality and morbidity of the he patitis A patients. Nineteen of 4024 (0.47%) patients died or re quired liver transplantion. Ten patients died due to fulminant hepatic failure and 9 patients received liver transplants, and 5 of the transplanted patients survived. The incidence of renal fail ure without combined fulminant hepatitis was 2.73%. The mean age of the 19 cases with mortality or transplantation was not different compared to that of total hepatitis A patients. Severe hepatic dysfunction and impairment of renal function was ob served in the mortality cases including death or liver transplan tation (Table 4) . HBV carrier rate was high in the mortality cases (3/19 patients, 15.8%), however, statistical analysis was not avail able due to great difference in a number of patients.
Comparison of clinical findings by age group
The severity of hepatitis A was compared between patients youn ger and older than 30 yr (Table 5 ). There was no significant dif ference in mortality. However, complication rates such as renal failure and cholestasis were significantly higher in the group older than 30 yr. Laboratory data revealed that levels of trans aminases, total bilirubin, and creatinine were significantly high er in the group older than 30 yr, and showed more prolonged prothrombin time and lower albumin in the group (Table 5) . Those results represented greater severity in hepatic and renal dysfunction in the group older than 30 yr. Interestingly, male/ female ratio was significantly different between the two groups. Proportion of male patients was higher in the group older than 30 yr. 
Data represents mean ± S.D. of the peak (highest or lowest) level during the followups. AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGTP, gamma glutamyl transpeptidase; WBC, white blood cell. 
DISCUSSION
This study demonstrated that symptomatic hepatitis A occurr ed primarily in adult populations, the mortality rate including death or liver transplantation was 0.47%, and a significant num ber of patients experienced complication of renal impairment or prolonged cholestasis. HAV infection used to be endemic in Korea and often occurred asymptomatically in early childhood with lifelong immunity. However, improvement in the econo mic status and general public health over the last 30 yr has led to a change in seroprevalence of hepatitis A (36). Recent stud ies have demonstrated that the positivity of antiHAV decreased to less than 10% in the children and adolescents, 20%30% in young adults and the seropositivity is over 90% in adults over 40 yr of age not only in Korea but also in many countries (4, 2022) . The decrease in HAV infection in young adults has resulted in an increase in the adult population that is susceptible to the in fection. In Korea, symptomatic hepatitis A has been increasing from mid 1990s; in 1998, a countrywide outbreak of the disease occurred. A nationwide study of hepatitis A from 1996 to 1998 including 1391 patients showed that their mean age was 26.5 yr, and most cases recovered uneventfully (23). Lee et al. (23) re ported that two cases (0.14%) with HAV superinfection among the chronic hepatitis B patients died of fulminant hepatitis. At present, the most common etiology of acute viral hepatitis is hepatitis A virus (50%90%) (24, 25) . In addition, hepatitis A is becoming a common etiology of fulminant hepatitis and an in creasing need for liver transplantation (26) . Surveillance data from KCDC showed that the incidence of hepatitis A was grad ually increasing after 2000, and large number of patients devel oped hepatitis from 2007 to 2009 (Fig. 3) (16) . This study includ ed 4,218 hepatitis A cases from the 21 participating institutions during the 2 yr of this study. The incidence of hepatitis A was highest in persons over age 30 yr. This result may suggest that the age of the population susceptible to hepatitis A is getting older and it may result in worse outcomes of the disease. Hepatitis A is a selflimited acute disease in most cases. Most children younger than 6 yr of age are asymptomatic or develop a mild selflimiting illness (27) . However, adults with HAV in fection can develop more severe symptoms, which can lead to serious complications (11, 28) . Therefore, the increasing inci dence of HAV infection due to changing seroepidemiology in adults might have an impact on morbidity and mortality. In this study, most patients had severe clinical manifestation of gastro intestinal symptoms and jaundice, and more than a half of the patients visited emergency room for the severe illness. Labora tory data also showed severe hepatitis in terms of abnormal liv er function test, the mean levels of peak ALT (2,963 IU/L) and total bilirubin (7.3 mg/dL). Also, unusual pattern of hepatitis A, such as cholestatic hepatitis, relapsing hepatitis or prolonged course, occurs in a considerable number of patients. In this study, most patients with hepatitis A recover uneventfully. However, fulminant hepatic failure occurred in 0.91% of the patients, and mortality rate including death or liver transplantation was 0.47%. This represents that hepatitis A is no longer a mild disease in the current situation as it presents in Korea. Unusual complica tions of hepatitis A were not rare. Acute renal failure occurred in 2.73% of the patients, and some patients were treated with renal replacement therapy. Acute renal failure without fulmi nant hepatitis is not uncommon during the course of hepatitis A. The patients with the acute renal failure have more severe hepatitis than those without renal failure, however, most cases have a good prognosis. Cholestatic hepatitis with prolonged cho lestasis and pruritus was observed during the disease course in 1.92% of the patients. The prolonged cholestasis and itching in hepatitis A usually has a benign course, however, they results in decrease in the patients' quality of life, prolonged duration of admission, and increase in the medical costs (13, 19) . The inci dences of the complications were different between our study and previously published data in 1998 from Korea. They report ed the complication rate of prolonged cholestasis was 4.7% and acute kidney injury was 1.5% (23) . This discrepancy could be in part due to different criteria of the complication and character istics of patients enrolled. The 19 mortality cases had similar characteristics of age and gender to the included patients. Hep atitis A may lead to a serious morbidity or mortality in those pa tients with chronic liver disease (29) . The seroprevalence of HAV infection in patients with chronic liver diseases is similar to that in general population by age (30, 31) . It has been reported that the clinical features of hepatitis A are severe in patients with chronic HBV infection (32, 33) . However, the clinical impact of chronic hepatitis B on the prognosis of hepatitis A is still contro versial. Kim et al. (33) reported that acute hepatitis A superim posed on chronic HBV infection is associated with serious mor bidity and mortality including acute liver failure compared with acute hepatitis alone. Our data revealed that the prevalence of HBsAg in the study population was 3.7%, which is a similar rate in young Korean adults. The HBV carrier rate was high in the mortality cases (15.8%), though statistical significance could not be analyzed due to small number the mortality cases as compared with the study population. Seroprevalence of HAV was low in young and middleaged adults, therefore, catchup vaccination of HAV should be recommended particularly in chronic HBV carriers and cases with chronic liver diseases. Acute renal failure associated with nonfulminant hepatitis A is not uncommon in acute hepatitis A patients. The incidence of renal failure is reported as 1%5% and has increasing tenden cy by age (13, 15) . The prognosis of renal failure acute hepatitis A is generally benign, although the patients with acute renal fail ure experience severe hepatitis in terms of clinical outcome and laboratory findings (15) . Some patients need renal replacement therapy and prolonged admission, however, permanent renal complication does not occur. In this large scale study, the inciden ce of acute renal failure in nonfulminant cases was 2.73% (108/ 3949) and there was no mortality in the patients with renal fail ure. In addition to the renal complication, hepatic failure, cho lestatic hepatitis, or relapsing hepatitis were not rare in the hep atitis A patients. These complications lead to mortality or prolong ed course of recovery and much more medical and social costs.
The prognosis of hepatitis A is dependent on the age of patient. Young children less than 5 yr are usually asymptomatic, while most elder children and adults develop symptoms with jaundice and high levels of serum aminotransferase (11, 27, 28) . Recent studies revealed the seroprevalence of antiHAV is less than 50% in adult population of 20 yr to 40 yr (35, 20) . In this study, the median age of the patients was 33.3 yr, and substantial numbers of patients were over 40 yr. We compared the severity of hepati tis between the groups of the patients younger and older than 30 yr. The clinical manifestations including complications and laboratory data showed that the clinical course in terms of he patic dysfunction and renal complication was worse in the group of the patients older than 30 yr than in younger patients. These epidemiologic and clinical results suggest that the change of epidemiologic pattern of hepatitis A in our country may lead to increase the disease burden and increase in healthcare cost. Recently, most pediatricians recommend HAV vaccination dur ing childhood, although it is not included in universal immuni zation program in Korea. Catchup vaccination of HAV should be considered in the adult population to reduce community wide outbreak of symptomatic hepatitis A and its morbidity.
This study was a largescale, nationwide study of symptom atic hepatitis A, however, it had some limitations. First, only pa tients from tertiary referral centers were included. This is likely to largely influence the complication rates seen with acute hep atitis A. We included the patients visiting outpatient clinic as well as patients with admission. However, the morbidity and mortality rates might be overestimated by the patients' charac teristics enrolled. Second, this data did not show the genotype distribution, which could be associated with the different se verity of the disease. This demonstrated the clinical manifesta tions of the acute hepatitis A in a large number of cases. The ge notypic differences of genotypes in recent outbreak and poten tial confounding factors should be investigated for the predic tion of outcomes and prevention of hepatitis A.
In conclusion, symptomatic hepatitis A in adulthood occurs frequently in Korea, and the changing epidemiologic pattern of the disease may increase disease severity and incidence of com plications. Strategies of vaccination against HAV in adult popu lation, as well as children, should be established for the preven tion of potential outbreaks of hepatitis A and decrease the dis ease burden.
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